Jan 19, 2021, 5:10 PM
Journalist ID: 1842
News Code: 84190757
0 Persons


Iran, Cuba joint COVID-19 vaccine starts new phase of human testing in Havana

Tehran, Jan 19, IRNA – The jointly produced COVID-19 vaccine of Iran and Cuba, Soberana 2, has successfully and with no complications passed the first and second phases.

The phase 2b of the clinical trial of the vaccine was launched on Tuesday and will go on for three weeks, during which 900 volunteers, aged between 19 and 80 years old, will receive the dose, according to Spain’s Agencia EFE.

Cuba’s Finlay Vaccine Institute and Iran's Pasteur Institute of Iran are jointly testing the most advanced vaccine from among the four choices of Havana.

On January 9, Cuba reached an agreement with Iran that if the first and second phases are successful, the third phase of clinical trials will be done in Tehran.

So far, the vaccine has been injected to 140 people, none of whom have suffered any side effects.

COVID-19 has infected 18,443 people in Cuba, but the country has not imported any of the vaccines used by other countries, Havana seems to be after using the vaccine produced in cooperation with Iran.


Follow us on Twitter @IrnaEnglish

Your Comment

You are replying to: .